Your healthcare team will assess tolerability, side effects, blood glucose control (if applicable), weight changes, and whether dose adjustment is needed
What truly makes our approach different is our foundation in science
Contact Americas Wellness Group to get started!
For the detail on the No-DAC versus DAC forms, see the CJC-1295 (No DAC) page
Ciccocioppo R, Economidou D, Cippitelli A, Cucculelli M, Ubaldi M, Soverchia L, Lourdusamy A, Massi M (2006) Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism
Tirzepatide, by contrast, is a dual GIP/GLP-1 receptor agonistit activates both the glucagon-like peptide-1 receptor and the glucose-dependent insulinotropic polypeptide receptor